{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:06:05Z","timestamp":1791417965337,"version":"4.3.3"},"reference-count":146,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.kint.2016.03.039","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T04:37:06Z","timestamp":1465274226000},"page":"753-763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Phosphate\u2014a poison for humans?"],"prefix":"10.1016","volume":"90","author":[{"given":"Hirotaka","family":"Komaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2016.03.039_bib1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/anie.196906601","article-title":"Phosphorus. From elemental light to chemical element","volume":"8","author":"Krafft","year":"1969","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.kint.2016.03.039_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1042\/CS20100377","article-title":"Phosphate toxicity: new insights into an old problem","volume":"120","author":"Razzaque","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.kint.2016.03.039_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/kisup.2013.88","article-title":"A\u00a0phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease","volume":"3","author":"Kuro-o","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2016.03.039_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ki.2009.466","article-title":"FGF23-parathyroid interaction: implications in chronic kidney disease","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib6","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2215\/CJN.00810110","article-title":"Serum phosphate and mortality in patients with chronic kidney disease","volume":"5","author":"Eddington","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib7","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.03.039_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1744-9987.12030","article-title":"Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients","volume":"17","author":"Taniguchi","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.kint.2016.03.039_bib10","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2016.03.039_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.kint.2016.03.039_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1681\/ASN.2008020141","article-title":"Serum phosphorus levels associate with coronary atherosclerosis in young adults","volume":"20","author":"Foley","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib13","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2215\/CJN.03950609","article-title":"Phosphorus additives in food and their effect in dialysis patients","volume":"4","author":"Uribarri","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2215\/CJN.06080809","article-title":"Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease","volume":"5","author":"Kalantar-Zadeh","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib15","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1681\/ASN.2009050559","article-title":"Intestinal npt2b plays a major role in phosphate absorption and homeostasis","volume":"20","author":"Sabbagh","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib16","doi-asserted-by":"crossref","first-page":"C487","DOI":"10.1152\/ajpcell.00412.2001","article-title":"Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)2 vitamin D3","volume":"282","author":"Xu","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.kint.2016.03.039_bib17","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1152\/ajprenal.00375.2003","article-title":"Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice","volume":"287","author":"Segawa","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2016.03.039_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib19","doi-asserted-by":"crossref","first-page":"F671","DOI":"10.1152\/ajprenal.00156.2009","article-title":"Npt2a and Npt2c in mice play distinct and synergistic roles in inorganic phosphate metabolism and skeletal development","volume":"297","author":"Segawa","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2016.03.039_bib20","doi-asserted-by":"crossref","first-page":"C159","DOI":"10.1152\/ajpcell.00456.2004","article-title":"Parathyroid hormone treatment induces dissociation of type IIa Na+-P(i) cotransporter-Na+\/H+ exchanger regulatory factor-1 complexes","volume":"289","author":"D\u00e9liot","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.kint.2016.03.039_bib21","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1172\/JCI32738","article-title":"Parathyroid hormone inhibits renal phosphate transport by phosphorylation of serine 77 of sodium-hydrogen exchanger regulatory factor-1","volume":"117","author":"Weinman","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.03.039_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.03.039_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.03.039_bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.kint.2016.03.039_bib25","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by Klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2016.03.039_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse Klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.kint.2016.03.039_bib27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.2008070783","article-title":"Initial FGF23-mediated signaling occurs in the distal convoluted tubule","volume":"20","author":"Farrow","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib28","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1681\/ASN.2012010048","article-title":"Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism","volume":"23","author":"Olauson","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib29","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1681\/ASN.2013111209","article-title":"The kidney is the principal organ mediating klotho effects","volume":"25","author":"Lindberg","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bone.2012.05.015","article-title":"FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1\/2-SGK1 signaling pathway","volume":"51","author":"Andrukhova","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.kint.2016.03.039_bib31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","article-title":"Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism","volume":"75","author":"Hu","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.kint.2016.03.039_bib32","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1096\/fj.10-154765","article-title":"Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule","volume":"24","author":"Hu","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2016.03.039_bib33","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in\u00a0vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.03.039_bib34","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jbmr.5650110714","article-title":"Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in\u00a0vitro","volume":"11","author":"Almaden","year":"1996","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.03.039_bib35","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.03.039_bib36","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.03.039_bib37","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.03.039_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00774-007-0779-3","article-title":"Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans","volume":"25","author":"Ito","year":"2007","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.kint.2016.03.039_bib39","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00774-015-0651-9","article-title":"Phosphate enhances Fgf23 expression through reactive oxygen species in UMR-106 cells","volume":"34","author":"Hori","year":"2016","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.kint.2016.03.039_bib41","doi-asserted-by":"crossref","first-page":"11085","DOI":"10.1073\/pnas.0704446104","article-title":"Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption","volume":"104","author":"Berndt","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2016.03.039_bib42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.03.039_bib43","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib44","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib45","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.2015.231","article-title":"Key role of the kidney in the regulation of fibroblast growth factor 23","volume":"88","author":"Mace","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ki.2013.537","article-title":"The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease","volume":"86","author":"Taal","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib47","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1681\/ASN.2014010104","article-title":"Proteinuria increases plasma phosphate by altering its tubular handling","volume":"26","author":"de Seigneux","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI17202","article-title":"The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification","volume":"112","author":"Schafer","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.03.039_bib49","doi-asserted-by":"crossref","first-page":"22144","DOI":"10.1074\/jbc.M300744200","article-title":"The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex","volume":"278","author":"Price","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2016.03.039_bib50","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/bonekey.2015.39","article-title":"The role of fetuin-A in mineral trafficking and deposition","volume":"4","author":"Cai","year":"2015","journal-title":"Bonekey Rep"},{"key":"10.1016\/j.kint.2016.03.039_bib51","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCRESAHA.111.261479","article-title":"Clearance of fetuin-A-containing calciprotein particles is mediated by scavenger receptor-A","volume":"111","author":"Herrmann","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2016.03.039_bib52","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/kisup.2013.96","article-title":"Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients","volume":"3","author":"Streja","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2016.03.039_bib53","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/ndt\/gfr384","article-title":"Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism","volume":"27","author":"Koizumi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2016.03.039_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial","volume":"132","author":"Moe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2016.03.039_bib55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0272-6386(04)00817-0","article-title":"Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism","volume":"44","author":"Sato","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.03.039_bib56","doi-asserted-by":"crossref","first-page":"E652","DOI":"10.1210\/jc.2013-4050","article-title":"Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism","volume":"99","author":"Takahashi","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.03.039_bib57","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","article-title":"Survival following parathyroidectomy among United States dialysis patients","volume":"66","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib58","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2015.72","article-title":"Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"88","author":"Komaba","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib59","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.03.039_bib60","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ki.2013.289","article-title":"AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients","volume":"85","author":"Martin","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib61","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJM197205182862009","article-title":"On the pathogenesis of the uremic state. An exposition of the \u2018trade-off hypothesis\u2019","volume":"286","author":"Bricker","year":"1972","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.03.039_bib62","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib63","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.03.039_bib64","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ki.2009.414","article-title":"Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib65","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ki.2009.464","article-title":"Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease","volume":"77","author":"Galitzer","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib66","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI111365","article-title":"Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency","volume":"73","author":"Portale","year":"1984","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.03.039_bib67","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1681\/ASN.2006121385","article-title":"Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice","volume":"18","author":"Stubbs","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib68","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.273.9.5253","article-title":"RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate","volume":"273","author":"Moallem","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2016.03.039_bib69","doi-asserted-by":"crossref","first-page":"F1096","DOI":"10.1152\/ajprenal.00167.2005","article-title":"A\u00a0critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease","volume":"289","author":"Cozzolino","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2016.03.039_bib70","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3 encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2016.03.039_bib71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Pages","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.kint.2016.03.039_bib72","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1210\/jc.2004-2238","article-title":"A\u00a0novel recessive mutation in fibroblast growth factor-23 (FGF23) causes familial tumoral calcinosis","volume":"90","author":"Larsson","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.03.039_bib73","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1210\/jc.2005-0301","article-title":"A\u00a0novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis","volume":"90","author":"Araya","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.03.039_bib74","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","article-title":"A\u00a0homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis","volume":"117","author":"Ichikawa","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.03.039_bib75","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1074\/jbc.M602469200","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation","volume":"281","author":"Kato","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2016.03.039_bib76","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/jbmr.061105","article-title":"Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23","volume":"22","author":"Frishberg","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.03.039_bib77","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2016.03.039_bib78","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1046\/j.1523-1755.2002.00625.x","article-title":"Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells","volume":"62","author":"Chen","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib79","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","article-title":"Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins","volume":"61","author":"Moe","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib80","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.ajpath.2015.03.020","article-title":"Runx2 expression in smooth muscle cells is required for arterial medial calcification in mice","volume":"185","author":"Lin","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2016.03.039_bib81","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib82","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.2009060640","article-title":"Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification","volume":"21","author":"Shroff","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib83","doi-asserted-by":"crossref","first-page":"F1418","DOI":"10.1152\/ajprenal.00633.2013","article-title":"Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia","volume":"306","author":"Yamada","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2016.03.039_bib84","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","article-title":"Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification","volume":"98","author":"Li","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2016.03.039_bib85","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.2010.390","article-title":"Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in\u00a0vitro","volume":"79","author":"Sage","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib86","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/CIRCRESAHA.108.181305","article-title":"Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization","volume":"103","author":"Ewence","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2016.03.039_bib87","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1681\/ASN.2009090944","article-title":"Fetuin-mineral complex reflects extraosseous calcification stress in CKD","volume":"21","author":"Hamano","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib88","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/ndt\/gfr609","article-title":"Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD","volume":"27","author":"Smith","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2016.03.039_bib89","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.111.053405","article-title":"Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23","volume":"125","author":"Lim","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2016.03.039_bib90","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","article-title":"Fibroblast growth factor 23 is not associated with and does not induce arterial calcification","volume":"83","author":"Scialla","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib91","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.2013.332","article-title":"Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency","volume":"85","author":"Jimbo","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib92","doi-asserted-by":"crossref","first-page":"F1381","DOI":"10.1152\/ajprenal.00003.2008","article-title":"Increased inorganic phosphate induces human endothelial cell apoptosis in\u00a0vitro","volume":"294","author":"Di Marco","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2016.03.039_bib93","doi-asserted-by":"crossref","first-page":"e23268","DOI":"10.1371\/journal.pone.0023268","article-title":"Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability","volume":"6","author":"Peng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2016.03.039_bib94","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1681\/ASN.2008101106","article-title":"Dietary phosphorus acutely impairs endothelial function","volume":"20","author":"Shuto","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib95","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ajkd.2011.11.007","article-title":"Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial","volume":"59","author":"Yilmaz","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.03.039_bib96","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1681\/ASN.2005040392","article-title":"Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study","volume":"16","author":"Ayus","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib97","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/heartjnl-2011-300570","article-title":"Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study","volume":"98","author":"Chue","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.kint.2016.03.039_bib98","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1046\/j.1523-1755.2003.00864.x","article-title":"Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia","volume":"63","author":"Amann","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib99","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/j.1523-1755.2004.66013.x","article-title":"Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure","volume":"66","author":"Neves","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib100","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Guti\u00e9rrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2016.03.039_bib101","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.03.039_bib102","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.kint.2016.03.039_bib103","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.kint.2016.03.039_bib104","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0008-6363(97)00194-6","article-title":"Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide","volume":"37","author":"Schl\u00fcter","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.kint.2016.03.039_bib105","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/ki.2009.308","article-title":"Acute phosphate nephropathy","volume":"76","author":"Markowitz","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib106","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1980.85","article-title":"Renal toxicity of phosphate in rats","volume":"17","author":"Haut","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib107","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3177\/jnsv.54.237","article-title":"Role of low protein and low phosphorus diet in the progression of chronic kidney disease in uremic rats","volume":"54","author":"Kusano","year":"2008","journal-title":"J\u00a0Nutr Sci Vitaminol (Tokyo)"},{"key":"10.1016\/j.kint.2016.03.039_bib108","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0006-291X(02)00793-3","article-title":"Role of dietary phosphorus in the progression of renal failure","volume":"295","author":"Koizumi","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.kint.2016.03.039_bib109","first-page":"54","article-title":"The decline of renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet","volume":"21","author":"Barsotti","year":"1984","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib110","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders in mineral metabolism with progression of chronic kidney disease","volume":"1","author":"Schwarz","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib111","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib112","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2016.03.039_bib113","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2215\/CJN.08680811","article-title":"Combined use of vitamin D status and FGF23 for risk stratification of renal outcome","volume":"7","author":"Nakano","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib114","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1681\/ASN.2014020218","article-title":"Serum fibroblast growth factor-23 is associated with incident kidney disease","volume":"26","author":"Rebholz","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1681\/ASN.2014060621","article-title":"The biomarker niche for fibroblast growth factor 23 testing in CKD","volume":"26","author":"Wolf","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib116","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1523-1755.2003.00126.x","article-title":"Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats","volume":"64","author":"Katsumata","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib117","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients","volume":"19","author":"Ferreira","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib118","first-page":"284","article-title":"Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years","volume":"70","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib119","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","article-title":"Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in\u00a0vitro","volume":"23","author":"Wang","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.03.039_bib120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jbmr.2606","article-title":"FGF23 regulates bone mineralization in a 1,25(OH)2D3 and Klotho-independent manner","volume":"31","author":"Murali","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.03.039_bib121","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jbmr.263","article-title":"Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men","volume":"26","author":"Mirza","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.03.039_bib122","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jbmr.2750","article-title":"Associations of FGF23 with change in bone mineral density and fracture risk in older individuals","volume":"31","author":"Isakova","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2016.03.039_bib123","first-page":"3182","article-title":"The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc","volume":"131","author":"Morishita","year":"2001","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.kint.2016.03.039_bib124","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCGENETICS.108.847814","article-title":"In\u00a0vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels","volume":"2","author":"Ohnishi","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.kint.2016.03.039_bib125","doi-asserted-by":"crossref","first-page":"e1000154","DOI":"10.1371\/journal.pgen.1000154","article-title":"Genetic evidence of serum phosphate-independent functions of FGF-23 on bone","volume":"4","author":"Sitara","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/j.kint.2016.03.039_bib126","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1096\/fj.09-152488","article-title":"Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging","volume":"24","author":"Ohnishi","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2016.03.039_bib127","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1093\/ndt\/gfs362","article-title":"Dietary phosphate modifies lifespan in","volume":"27","author":"Bergwitz","year":"2012","journal-title":"Drosophila. Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2016.03.039_bib128","doi-asserted-by":"crossref","first-page":"E933","DOI":"10.1152\/ajpendo.00009.2015","article-title":"Mitochondrial oxidative stress mediates high-phosphate-induced secretory defects and apoptosis in insulin-secreting cells","volume":"308","author":"Nguyen","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.03.039_bib129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200802-306OC","article-title":"High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling","volume":"179","author":"Jin","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.kint.2016.03.039_bib130","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.03.039_bib131","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1074\/jbc.M113.527150","article-title":"FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis","volume":"289","author":"Coe","year":"2014","journal-title":"J\u00a0Biol Chem"},{"issue":"Suppl 1","key":"10.1016\/j.kint.2016.03.039_bib132","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.ASN.0000093369.09194.12","article-title":"Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach","volume":"15","author":"Brancaccio","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib133","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1172\/JCI83470","article-title":"FGF23 signaling impairs neutrophil recruitment and host defense during CKD","volume":"126","author":"Rossaint","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.03.039_bib134","doi-asserted-by":"crossref","first-page":"418695","DOI":"10.1155\/2010\/418695","article-title":"Effects of parathyroid hormone on immune function","volume":"2010","author":"Geara","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.kint.2016.03.039_bib135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cmet.2015.11.003","article-title":"PTH\/PTHrP receptor mediates cachexia in models of kidney failure and cancer","volume":"23","author":"Kir","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.kint.2016.03.039_bib136","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2016.03.039_bib137","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib138","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2011.12.025","article-title":"Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status","volume":"60","author":"Lopes","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.03.039_bib139","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/ki.2013.185","article-title":"Use of phosphate-binding agents is associated with a lower risk of mortality","volume":"84","author":"Cannata-And\u00eda","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.03.039_bib140","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.03.039_bib141","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2016.03.039_bib142","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib143","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2012070719","article-title":"Cardiovascular effects of sevelamer in stage 3 CKD","volume":"24","author":"Chue","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib144","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1681\/ASN.2011121213","article-title":"Npt2b deletion attenuates hyperphosphatemia associated with CKD","volume":"23","author":"Schiavi","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib145","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1681\/ASN.2015020117","article-title":"Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD","volume":"26","author":"Isakova","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.03.039_bib146","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jama.2013.252441","article-title":"Prevalence of reduced estimated glomerular filtration rate among the oldest old from 1988-1994 through 2005-2010","volume":"310","author":"Bowling","year":"2013","journal-title":"JAMA"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816301375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816301375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T01:56:31Z","timestamp":1601517391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253816301375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":146,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0085253816301375"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2016.03.039","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphate\u2014a poison for humans?","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2016.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016, International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}